COVID-19 in Fabry disease: a reference center prospective study.

Christina BothouLanja SalehArnold von EckardsteinFelix BeuschleinAlbina Nowak

Published in: Orphanet journal of rare diseases (2022)

Similar to the general population, in FD patients the risk for severe COVID-19 seems to be driven by the immune system rather than by FD itself. Immunosuppression in kidney transplant recipients represented the highest risk in this population.

Keyphrases

coronavirus disease
sars cov
end stage renal disease
ejection fraction
newly diagnosed
peritoneal dialysis
prognostic factors
heart failure
early onset
patient reported outcomes
atrial fibrillation
drug induced
smoking cessation